H

Hyphens Pharma International Ltd
SGX:1J5

Watchlist Manager
Hyphens Pharma International Ltd
SGX:1J5
Watchlist
Price: 0.28 SGD -1.75% Market Closed
Market Cap: 86.6m SGD

Hyphens Pharma International Ltd
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hyphens Pharma International Ltd
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
H
Hyphens Pharma International Ltd
SGX:1J5
Long-Term Investments
S$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WAVE Life Sciences Ltd
NASDAQ:WVE
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Haw Par Corporation Ltd
SGX:H02
Long-Term Investments
S$3.4B
CAGR 3-Years
9%
CAGR 5-Years
5%
CAGR 10-Years
4%
I
IX Biopharma Ltd
SGX:42C
Long-Term Investments
S$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

Hyphens Pharma International Ltd
Glance View

Market Cap
86.5m SGD
Industry
Pharmaceuticals

Hyphens Pharma International Ltd. is an investment holding company, which engages in the provision of specialty pharmaceutical and consumer healthcare products. The firm's principal activities are those of an investment holding company and provision of management services. The firm's segments include specialty pharma principals, proprietary brands, and medical hypermart and digital. The specialty pharma principals segment is engaged in the business of marketing and selling a range of specialty pharmaceutical products with exclusivity in the relevant ASEAN countries. The proprietary brands segment is engaged in the business of developing, marketing and selling its own proprietary range of dermatological products and health supplement products. The medical hypermart and digital segment is a wholesaler of pharmaceuticals and medical supplies in Singapore, which the Company and its subsidiaries position itself as a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies.

1J5 Intrinsic Value
0.47 SGD
Undervaluation 40%
Intrinsic Value
Price
H

See Also

What is Hyphens Pharma International Ltd's Long-Term Investments?
Long-Term Investments
0 SGD

Based on the financial report for Dec 31, 2024, Hyphens Pharma International Ltd's Long-Term Investments amounts to 0 SGD.

Back to Top